Nanostructure of Cationic Lipid-oligonucleotide Complexes

Overview

Journal Biophys J

Publisher Cell Press

Specialty Biophysics

Date 2004 Jul 9

PMID 15240493

Citations 30

Authors

Sarah Weisman

Danielle Hirsch-Lerner

Yechezkel Barenholz

Yeshayahu Talmon

Affiliations

Soon will be listed here.

Abstract

Complexes (lipoplexes) between cationic liposomes and single-strand oligodeoxynucleotides (ODN) are potential delivery systems for antisense therapy. The nanometer-scale morphology of these assemblies is relevant to their transfection efficiency. In this work the monocationic lipid dioleoyloxytrimethylammoniumpropane, the neutral "helper" lipid cholesterol, and an 18-mer anti-bcl2 ODN were combined at different ratios. The lipoplexes formed were characterized for the quantity of ODN bound, for the degree of lipid mixing, and for their size. The nanostructure of the system was examined by cryogenic-temperature transmission electron microscopy, augmented by small-angle x-ray scattering. Addition of ODN to cationic liposomes induced both liposome aggregation and the formation of a novel condensed lamellar phase. This phase is proposed to be stabilized by anionic single-strand ODN molecules intercalated between cationic bilayers. The proportion of cholesterol present apparently did not affect the nature of lipoplex microstructure, but changed the interlamellar spacing.

Citing Articles

Lipid nanovehicles overcome barriers to systemic RNA delivery: Lipid components, fabrication methods, and rational design.

Yan J, Zhang H, Li G, Su J, Wei Y, Xu C Acta Pharm Sin B. 2024; 14(2):579-601.

PMID: 38322344 PMC: 10840434. DOI: 10.1016/j.apsb.2023.10.012.

Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures.

Meulewaeter S, Nuytten G, Cheng M, De Smedt S, Cullis P, Beer T J Control Release. 2023; 357:149-160.

PMID: 36958400 PMC: 10062427. DOI: 10.1016/j.jconrel.2023.03.039.

An immunogold single extracellular vesicular RNA and protein ( SERP) biochip to predict responses to immunotherapy in non-small cell lung cancer patients.

Nguyen L, Zhang J, Rima X, Wang X, Kwak K, Okimoto T J Extracell Vesicles. 2022; 11(9):e12258.

PMID: 36093740 PMC: 9465631. DOI: 10.1002/jev2.12258.

Anti- cholesterol based lipoplexes as onco-nanotherapeutic agents .

Habib S, Daniels A, Ariatti M, Singh M F1000Res. 2021; 9:770.

PMID: 33391729 PMC: 7745184. DOI: 10.12688/f1000research.25142.2.

Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment.

Gaspar R, Coelho F, Silva B Molecules. 2020; 25(21).

PMID: 33126767 PMC: 7662579. DOI: 10.3390/molecules25215006.

References

Leamon C, Cooper S, Hardee G . Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo. Bioconjug Chem. 2003; 14(4):738-47. DOI: 10.1021/bc020089t. View

Templeton N, Lasic D, Frederik P, Strey H, Roberts D, Pavlakis G . Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol. 1997; 15(7):647-52. DOI: 10.1038/nbt0797-647. View

Gustafsson J, Arvidson G, Karlsson G, Almgren M . Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim Biophys Acta. 1995; 1235(2):305-12. DOI: 10.1016/0005-2736(95)80018-b. View

Akhtar S . Antisense technology: selection and delivery of optimally acting antisense oligonucleotides. J Drug Target. 1998; 5(4):225-34. DOI: 10.3109/10611869808995877. View

Tamm I, Dorken B, Hartmann G . Antisense therapy in oncology: new hope for an old idea?. Lancet. 2001; 358(9280):489-97. DOI: 10.1016/S0140-6736(01)05629-X. View

Dass C . Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy. Int J Pharm. 2002; 241(1):1-25. DOI: 10.1016/s0378-5173(02)00194-1. View

Bennett C, Chiang M, Chan H, Shoemaker J, Mirabelli C . Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol. 1992; 41(6):1023-33. View

Alinchenko M, Voloshin V, Medvedev N, Mezei M, Partay L, Jedlovszky P . Effect of cholesterol on the properties of phospholipid membranes. 4. Interatomic voids. J Phys Chem B. 2006; 109(34):16490-502. DOI: 10.1021/jp051832s. View

Radler J, Koltover I, Salditt T, Safinya C . Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science. 1997; 275(5301):810-4. DOI: 10.1126/science.275.5301.810. View

10.

Simberg D, Weisman S, Talmon Y, Faerman A, Shoshani T, Barenholz Y . The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection. J Biol Chem. 2003; 278(41):39858-65. DOI: 10.1074/jbc.M302232200. View

11.

Huebner S, Battersby B, Grimm R, Cevc G . Lipid-DNA complex formation: reorganization and rupture of lipid vesicles in the presence of DNA as observed by cryoelectron microscopy. Biophys J. 1999; 76(6):3158-66. PMC: 1300284. DOI: 10.1016/S0006-3495(99)77467-9. View

12.

Flaherty K, Stevenson J, ODwyer P . Antisense therapeutics: lessons from early clinical trials. Curr Opin Oncol. 2001; 13(6):499-505. DOI: 10.1097/00001622-200111000-00013. View

13.

Lebedeva I, Stein C . Antisense oligonucleotides: promise and reality. Annu Rev Pharmacol Toxicol. 2001; 41:403-19. DOI: 10.1146/annurev.pharmtox.41.1.403. View

14.

Bellare J, Davis H, Scriven L, Talmon Y . Controlled environment vitrification system: an improved sample preparation technique. J Electron Microsc Tech. 1988; 10(1):87-111. DOI: 10.1002/jemt.1060100111. View

15.

Meidan V, Cohen J, Amariglio N, Barenholz Y . Interaction of oligonucleotides with cationic lipids: the relationship between electrostatics, hydration and state of aggregation. Biochim Biophys Acta. 2000; 1464(2):251-61. DOI: 10.1016/s0005-2736(00)00151-6. View